3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Neuroendocrine
2
Breast Neoplasms
2
Thyroid Neoplasms
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myocarditis
1
Multiple Pulmonary Nodules
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Liver Metastases
1
Liver Malignancy
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Intraabdominal Infections
1
Head and Neck Neoplasms
1
Interventions
Oxaliplatin
19
pembrolizumab
13
Fluorouracil
12
Leucovorin
11
Capecitabine
11
Paclitaxel
10
Gemcitabine
9
Docetaxel
8
zolbetuximab
6
cemiplimab
6
Cisplatin
6
Albumin-Bound Paclitaxel
6
durvalumab
5
Ramucirumab
5
Radiotherapy
5
130-nm albumin-bound paclitaxel
5
Irinotecan
4
Cyclophosphamide
4
trastuzumab deruxtecan
3
tislelizumab
3
lenvatinib
3
enzalutamide
3
darolutamide
3
Trastuzumab
3
Taxes
3
S 1 (combination)
3
Radiosurgery
3
Pemetrexed
3
Nivolumab
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Positron Emission Tomography Computed Tomography
×
1 year
×
Clear all
No trials found.